295 related articles for article (PubMed ID: 9300242)
1. Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor.
Morishita R; Higaki J; Hayashi SI; Yo Y; Aoki M; Nakamura S; Moriguchi A; Matsushita H; Matsumoto K; Nakamura T; Ogihara T
Diabetologia; 1997 Sep; 40(9):1053-61. PubMed ID: 9300242
[TBL] [Abstract][Full Text] [Related]
2. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes.
Morishita R; Nakamura S; Nakamura Y; Aoki M; Moriguchi A; Kida I; Yo Y; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Diabetes; 1997 Jan; 46(1):138-42. PubMed ID: 8971094
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.
Aoki M; Morishita R; Hayashi S; Jo N; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Diabetologia; 2001 Aug; 44(8):1034-42. PubMed ID: 11484082
[TBL] [Abstract][Full Text] [Related]
4. Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells.
Yo Y; Morishita R; Nakamura S; Tomita N; Yamamoto K; Moriguchi A; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Kidney Int; 1998 Oct; 54(4):1128-38. PubMed ID: 9767528
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of local hepatocyte growth factor expression by angiotensin II and transforming growth factor-beta in blood vessels: potential role of HGF in cardiovascular disease.
Nakano N; Morishita R; Moriguchi A; Nakamura Y; Hayashi SI; Aoki M; Kida I; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Hypertension; 1998 Sep; 32(3):444-51. PubMed ID: 9740609
[TBL] [Abstract][Full Text] [Related]
6. Impaired endothelial dysfunction in diabetes mellitus rats was restored by oral administration of prostaglandin I2 analogue.
Matsumoto K; Morishita R; Tomita N; Moriguchi A; Yamasaki K; Aoki M; Matsumoto K; Nakamura T; Higaki J; Ogihara T
J Endocrinol; 2002 Oct; 175(1):217-23. PubMed ID: 12379506
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol Induces PGI2 Production via Activation of the Downstream Epac-1/Rap1 Signaling Cascade to Increase Intracellular Calcium by PLCε and to Activate p44/42 MAPK in Human Aortic Endothelial Cells.
Hashimoto A; Tanaka M; Takeda S; Ito H; Nagano K
PLoS One; 2015; 10(7):e0132835. PubMed ID: 26181635
[TBL] [Abstract][Full Text] [Related]
8. Improvement of endothelial dysfunction by angiotensin II blockade accompanied by induction of vascular hepatocyte growth factor system in diabetic spontaneously hypertensive rats.
Matsumoto K; Morishita R; Tomita N; Moriguchi A; Komai N; Aoki M; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Heart Vessels; 2003 Mar; 18(1):18-25. PubMed ID: 12644877
[TBL] [Abstract][Full Text] [Related]
9. Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor.
Makino H; Aoki M; Hashiya N; Yamasaki K; Hiraoka K; Shimizu H; Azuma J; Kurinami H; Ogihara T; Morishita R
Hypertens Res; 2004 Feb; 27(2):85-91. PubMed ID: 15005271
[TBL] [Abstract][Full Text] [Related]
10. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration.
Matsumoto K; Okazaki H; Nakamura T
J Biochem; 1995 Feb; 117(2):458-64. PubMed ID: 7608139
[TBL] [Abstract][Full Text] [Related]
11. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells.
Hayashi S; Morishita R; Higaki J; Aoki M; Moriguchi A; Kida I; Yoshiki S; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Biochem Biophys Res Commun; 1996 Mar; 220(3):539-45. PubMed ID: 8607801
[TBL] [Abstract][Full Text] [Related]
12. Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-γ and cAMP Pathways in Vascular Cells.
Sanada F; Kanbara Y; Taniyama Y; Otsu R; Carracedo M; Ikeda-Iwabu Y; Muratsu J; Sugimoto K; Yamamoto K; Rakugi H; Morishita R
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):545-52. PubMed ID: 26769045
[TBL] [Abstract][Full Text] [Related]
13. Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease.
Yo Y; Morishita R; Yamamoto K; Tomita N; Kida I; Hayashi S; Moriguchi A; Kato S; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Kidney Int; 1998 Jan; 53(1):50-8. PubMed ID: 9452999
[TBL] [Abstract][Full Text] [Related]
14. Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles.
Nakamura K; Ikomi F; Ohhashi T
J Vasc Res; 2006; 43(1):86-94. PubMed ID: 16286783
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-alpha in vascular endothelial cells.
Nishio Y; Kashiwagi A; Takahara N; Hidaka H; Kikkawa R
Horm Metab Res; 1997 Oct; 29(10):491-5. PubMed ID: 9405974
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane.
Nakagami H; Morishita R; Yamamoto K; Taniyama Y; Aoki M; Yamasaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Diabetes; 2002 Aug; 51(8):2604-11. PubMed ID: 12145177
[TBL] [Abstract][Full Text] [Related]
19. Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells.
Ota H; Eto M; Kano MR; Ogawa S; Iijima K; Akishita M; Ouchi Y
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1634-9. PubMed ID: 18556572
[TBL] [Abstract][Full Text] [Related]
20. Anti-apoptotic action of hepatocyte growth factor through mitogen-activated protein kinase on human aortic endothelial cells.
Nakagami H; Morishita R; Yamamoto K; Taniyama Y; Aoki M; Kim S; Matsumoto K; Nakamura T; Higaki J; Ogihara T
J Hypertens; 2000 Oct; 18(10):1411-20. PubMed ID: 11057428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
